Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danish Hypertension Prevention Project
NCT00150631Phase 3Unknown
- Start
- Nov 2000
- Primary completion
- Jan 2004
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of candesartan in hypertension (HTN). Status: unknown.
02
Drugs
candesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00150631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150631.